1. Home
  2. FBRX vs KRSP Comparison

FBRX vs KRSP Comparison

Compare FBRX & KRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$27.32

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

KRSP

Rice Acquisition Corporation 3

N/A

Current Price

$10.28

Market Cap

474.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FBRX
KRSP
Founded
N/A
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
474.3M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FBRX
KRSP
Price
$27.32
$10.28
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$67.00
N/A
AVG Volume (30 Days)
385.9K
39.0K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.30
N/A
EPS
N/A
N/A
Revenue
$36,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$10.21
52 Week High
$35.80
$10.70

Technical Indicators

Market Signals
Indicator
FBRX
KRSP
Relative Strength Index (RSI) 44.26 53.64
Support Level $26.67 $10.30
Resistance Level $31.71 $10.39
Average True Range (ATR) 3.16 0.02
MACD -0.26 -0.00
Stochastic Oscillator 20.92 77.78

Price Performance

Historical Comparison
FBRX
KRSP

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

About KRSP Rice Acquisition Corporation 3

Rice Acquisition Corp 3 is a blank check company.

Share on Social Networks: